Sarah Ketterer - Causeway Capital Management
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,174,213 | 0.53 | Add 18.15% | 0.08 | $36.75 | $43,152,333 | SEC |
| 2025 Q4 | 993,850 | 0.70 | Add 42.80% | 0.21 | $50.88 | $50,567,080 | SEC |
| 2025 Q3 | 695,979 | 0.51 | Add 96.67% | 0.25 | $55.49 | $38,619,855 | SEC |
| 2025 Q2 | 353,884 | 0.39 | Buy | 0.39 | $69.02 | $24,425,058 | SEC |